Source:http://linkedlifedata.com/resource/pubmed/id/11180247
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2001-2-22
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0197-3851
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
72
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11180247-Biological Markers,
pubmed-meshheading:11180247-Down Syndrome,
pubmed-meshheading:11180247-Female,
pubmed-meshheading:11180247-Humans,
pubmed-meshheading:11180247-Neural Tube Defects,
pubmed-meshheading:11180247-Pregnancy,
pubmed-meshheading:11180247-Prenatal Diagnosis,
pubmed-meshheading:11180247-Quality Control
|
pubmed:year |
2001
|
pubmed:articleTitle |
Measuring serum markers once or twice in each assay in antenatal screening for Down syndrome and neural tube defects.
|
pubmed:publicationType |
Letter
|